The ARL6IP4 Knockout HEK293T Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population targeting the human ARL6IP4 gene. This heterogeneous pool of HEK293T cells carries diverse loss-of-function mutations, providing a robust model to study ARL6IP4-dependent processes without the constraints of clonal selection. The polyclonal format minimizes potential artifacts from single-cell expansion and preserves a broader representation of knockout phenotypes.
HEK293T cells are immortalized human embryonic kidney cells expressing the SV40 large T antigen, renowned for high transfectability and efficient protein production. Their genetic tractability and rapid growth make them a standard host for CRISPR-based gene editing and functional genomics, enabling detailed mechanistic studies in a well-defined cellular environment.
ARL6IP4 is a multi-pass membrane protein residing at the endoplasmic reticulum and mitochondria-associated membranes. It critically suppresses apoptosis by binding and sequestering caspase-8, thus blocking death receptor-mediated signaling. This function is regulated by upstream ER stress sensors IRE1, PERK, and ATF6, which respond to unfolded protein accumulation, and by pro-apoptotic cues. ARL6IP4 also interfaces with membrane trafficking through interactions with ARL6, ARL5B, and vesicle transport proteins. Downstream, its loss leads to caspase-8 activation and altered mitochondrial permeability, events modulated by Bcl-2 family members. Thus, ARL6IP4 integrates ER stress signaling with apoptotic control and intracellular trafficking dynamics.
In HEK293T cells, ARL6IP4 knockout abrogates its inhibitory interaction with caspase-8, sensitizing cells to apoptosis and ER stress insults. This model is valuable for exploring how disruption of ER-mitochondria contact sites and protein trafficking contributes to cell death, with direct relevance to hereditary spastic paraplegia and broader neurodegenerative research. Despite the non-neuronal background, core mechanisms of apoptosis and membrane dynamics are recapitulated.
This polyclonal knockout cell population supports diverse experimental workflows. Apoptosis and viability assays include Annexin V analysis, caspase-8 activity measurements, and MTT assays under ER stress or cytotoxic challenge. Protein interaction and localization studies employ co-immunoprecipitation, Western blotting, and immunofluorescence for caspase-8, ARL6, and trafficking markers. Mitochondrial morphology can be monitored via fluorescent probes, while RT-qPCR assesses transcriptional changes in UPR targets. The model is also suited for drug screening campaigns targeting spastic paraplegia-associated pathways. For further technical inquiries, please contact Ascent Research.
